IR@PKUHSC  > 北京大学第二临床医学院  > 肝胆外科
学科主题临床医学
3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells: in vitro and in vivo Findings
Gong, Lei1,2; Wei, Yuhua1; Yu, Xin1; Peng, Jirun1; Leng, Xisheng1
关键词Antitumor effect 3-Bromopyruvic acid hepatoma BEL-7402 cells Hexokinase II
刊名ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
2014-06-01
14期:5页:771-776
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Chemistry, Medicinal
研究领域[WOS]Oncology ; Pharmacology & Pharmacy
关键词[WOS]TARGETING CANCER METABOLISM ; HEPATOCELLULAR-CARCINOMA ; GLUCOSE-METABOLISM ; LIVER-TUMOR ; MODEL ; GLYCOLYSIS ; APOPTOSIS ; EFFICACY ; THERAPY ; WARBURG
英文摘要

Over-expressed in cancer cells, hexokinase II (HK II) forms a mitochondrial complex, which promotes cancer survival. 3-Bromopyruvic acid (3-BrPA) dissociates HK II from this complex, causing cell death, and thus, having an anti-tumor effect. The design of this study was to first analyze the expression of HK II in the hepatoma cell line, BEL-7402, then investigate the effects of 3-Br-PA on these cells, and finally, discuss its potential for clinical usage. HK II expression was detected in BEL-7402 cells by immunocytochemistry and reverse transcriptase polymerase chain reaction (RT-PCR). In vitro treatment of cells with 3-BrPA significantly inhibited their growth, as evaluated by MTT assay and adenosine triphosphate-tumor chemosensitivity assay (ATP-TCA). To analyze the in vivo function and safety of this drug, a tumor model was established by subcutaneously implanting hepatic cancer cells into nude mice. 3-BrPA treatment (50 mg/kg ip. daily, 6 days/week for three weeks) was effective in the animal model by attenuating tumor growth and causing tumor necrosis. Toxic signs were not observed. The acute toxicity study provided an LD50 of 191.7 mg/kg for 3-BrPA. Taken together, our in vitro and in vivo analyses suggest that 3-BrPA exerts anti-hepatoma effects, and may be an effective pharmacological agent for the treatment of hepatocellular carcinoma.

语种英语
WOS记录号WOS:000335390800015
引用统计
被引频次:11[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63699
专题北京大学第二临床医学院_肝胆外科
作者单位1.Peking Univ, Dept Hepatobiliary Surg, Peoples Hosp, Beijing 100044, Peoples R China
2.Tsinghua Univ, Dept Gen Surg, Beijing Tsinghua Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Gong, Lei,Wei, Yuhua,Yu, Xin,et al. 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells: in vitro and in vivo Findings[J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,2014,14(5):771-776.
APA Gong, Lei,Wei, Yuhua,Yu, Xin,Peng, Jirun,&Leng, Xisheng.(2014).3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells: in vitro and in vivo Findings.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,14(5),771-776.
MLA Gong, Lei,et al."3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells: in vitro and in vivo Findings".ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY 14.5(2014):771-776.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Gong, Lei]的文章
[Wei, Yuhua]的文章
[Yu, Xin]的文章
百度学术
百度学术中相似的文章
[Gong, Lei]的文章
[Wei, Yuhua]的文章
[Yu, Xin]的文章
必应学术
必应学术中相似的文章
[Gong, Lei]的文章
[Wei, Yuhua]的文章
[Yu, Xin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。